ASIAN SCIENTIST NEWSROOM
DECEMBER 20, 2011IBM has opened a branch office in Visakhapatnam, Southeast India as part of the company’s continued geographic expansion initiative to increase its presence in key growth markets.
AsianScientist (Dec. 20, 2011):
IBM announced this Monday the opening of a branch office in Visakhapatnam, Southeast India as part of the company’s continued geographic expansion initiative to increase its presence in key growth markets.
The new office was inaugurated by Mr. Sanjit Singh Lamba, Managing Director of Eisai Pharmaceuticals, one of IBM’s customers in the region.
In 2011 alone, the company opened six new branch offices in India as it expands its reach to smaller, rapidly developing cities as part of its plan to establish a presence in over 40 cities across India and South Asia by 2013.
Earlier this year IBM opened new branches in Coimbatore in the State of Tamilnadu, Indore in the State of Madhya Pradesh, Dehradun in the State of Uttarakhand, Guwahati in the State of Assam, and Raipur in the State of Chhattisgarh.
“India plays a key role in our growth market strategy and we have opened six new branches across the country this year taking us closer to our clients and partners in India’s rapidly evolving regional cities,” said Bruno Di Leo, General Manager, IBM Growth Markets Unit.
Visakhapatnam is an important port city in Southeast India, and has experienced rapid economic growth in recent years due to the development of petroleum, steel, fertilizer, and IT industries.
To support its regional expansion initiative, IBM has also been actively recruiting new business partners across the country – in 2011 over 1,000 new business partners from India/South Asia have registered via IBM’s PartnerWorld program.
Clients in Visakhapatnam include Eisai Pharmaceuticals, the Indian arm of Eisai Group, Japan; and Phoenix IT Solutions, a fast emerging software company.——
Source: IBM.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
source: http://www.asianscientist.com / Home> Tech & Pharma / December 20th, 2011